Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Medicine (Baltimore) ; 100(50): e28213, 2021 Dec 17.
Article in English | MEDLINE | ID: mdl-34918683

ABSTRACT

ABSTRACT: The transient occlusion of the terminal thoracic duct is a rare disease responsible for renitent supraclavicular cysts. The aim of this study was to describe the clinical characteristics, evolution, and treatment.A retrospective multicenter study and literature review was carried out. The literature search (PubMed) was conducted including data up to 31 December 2020 and PRISMA guidelines were respected.This study identified 6 observational cases between September 2010 and December 2020. The search results indicated a total of 24 articles of which 19 were excluded due to the lack of recurrent swelling or the unavailability of full texts (n = 5). Fourteen patients (8 from literature) mostly reported a noninflammatory, painless renitent mass in the supraclavicular fossa which appeared rapidly over a few hours and disappeared spontaneously over an average of 8 days (range: from about 2 hours to 10 days). Anamnesis indicated a high-fat intake during the preceding days in all cases and 7 from literature found in the Medline databases. Recurrences were noted in 10 patients. Thoracic duct imaging was performed in all cases to detect abnormalities or extrinsic compression as well as to eliminate differential diagnoses.A painless, fluctuating, noninflammatory, and recurrent swelling of the left supraclavicular fossa in patients evoking an intermittent obstruction of the terminal portion of the thoracic duct was identified. A low-fat diet was found as safe and effective treatment.


Subject(s)
Mediastinal Cyst/diagnostic imaging , Thoracic Duct/diagnostic imaging , Tomography, X-Ray Computed/methods , Aged , Female , Humans , Male , Mediastinal Cyst/pathology , Mediastinal Cyst/surgery , Middle Aged , Recurrence , Retrospective Studies , Thoracic Duct/pathology , Thoracic Duct/surgery , Treatment Outcome
2.
J Minim Invasive Gynecol ; 26(7): 1224-1225, 2019.
Article in English | MEDLINE | ID: mdl-30980992

ABSTRACT

STUDY OBJECTIVE: Laparoscopic resection of diaphragmatic endometriosis has the advantages of a minimally invasive approach [1]. The standardization and description of the technique are the main objectives of this video. We described the procedure in 10 steps to make it easier and safer. DESIGN: A step-by-step video demonstration of the technique (Video 1). SETTING: A French university tertiary care hospital. PATIENTS: Patients with diaphragmatic endometriosis confirmed by magnetic resonance imaging [2]. The local institutional review board ruled that approval was not required for this video article because the video describes a technique and does not report a clinical case. INTERVENTION: There are no guidelines on the surgical treatment of diaphragmatic endometriosis [3]. We propose a laparoscopic approach using a right lateral access with the patient in the left lateral decubitus position [4]. MEASUREMENTS AND MAIN RESULTS: This video presents the procedure divided into the following 10 steps: step 1, set up; step 2, patient position; step 3, installation of the trocars; step 4, releasing the liver; step 5, exposure of the diaphragmatic endometriosis; step 6, making a diaphragmatic defect; step 7, exploring the thoracic cavity; step 8, resection of diaphragmatic endometriosis; step 9, inserting the suction catheter; and step 10, closing the diaphragmatic defect. CONCLUSION: Standardization of laparoscopic resection of diaphragmatic endometriosis could make this procedure easier and safer to perform. The left lateral decubitus position helps to have complete exposure of the right diaphragmatic muscle and endometriosis. We presented 10 steps to help perform each part of the surgery in logical sequence, making the procedure ergonomic and easier to adopt and learn [5]. Standardization of laparoscopic techniques could help to reduce the learning curve.


Subject(s)
Diaphragm/surgery , Endometriosis/surgery , Laparoscopy/methods , Female , Humans
3.
Ann Thorac Surg ; 100(5): e103-5, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26522573

ABSTRACT

We report a case of intercostal muscle flap used in tracheobronchial reconstruction for extensive necrosis after burn lesions of the posterior wall. A 32-year-old man attempted suicide by ingestion of caustic material. He underwent emergency total esogastrectomy, tracheostomy, and feeding jejunostomy. Ten days later, endoscopy showed complete destruction of the membranous trachea, extending from the tracheostomy to the carina. Reconstruction was conducted with the patient under venovenous extracorporeal membrane oxygenation by use of a pedicled intercostal muscle flap. The patient was weaned from respiratory support on the 14th postoperative day. Examination of a biopsy specimen from the flap 7 months after tracheoplasty showed ciliated neoepithelium.


Subject(s)
Burns, Chemical/complications , Intercostal Muscles/transplantation , Plastic Surgery Procedures/methods , Surgical Flaps , Trachea/surgery , Tracheal Stenosis/surgery , Adult , Burns, Chemical/pathology , Burns, Chemical/surgery , Humans , Male , Necrosis/etiology , Necrosis/pathology , Necrosis/surgery , Suicide, Attempted , Trachea/injuries , Tracheal Stenosis/chemically induced
4.
Chin Clin Oncol ; 4(4): 40, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26730752

ABSTRACT

BACKGROUND: Whether prophylactic tracheotomy can shorten the duration of mechanical ventilation (MV) in high risk patients eligible for lung cancer resection. The objective was to compare duration of MV and outcome in 39 patients randomly assigned to prophylactic tracheotomy or control. METHODS: Prospective randomized controlled, single-center trial (ClinicalTrials.gov Identifier: NCT01053624). The primary outcome measure was the cumulative number of MV days after operation until discharge. The secondary outcome measures were the 60 days mortality rate, the ICU and the hospital length of stay, the incidence of postoperative respiratory, cardiac and general complications, the reventilation rate, the need of noninvasive ventilation (NIV), the need of a tracheotomy in control group and the tracheal complications. RESULTS: The duration of MV was not significantly different between the tracheotomy group (3.5±6 days) and the control group (4.7±9.3 days) (P=0.54). Among patients needing prolonged MV >4 days, tracheotomy patients had a shortened duration of MV than control patients (respectively 11.4±7.1 and 20.4±9.6 days, P=0.04). The rate of respiratory complications were significantly lower in the tracheotomy group than in the control group (28% vs. 51%, P=0.03). Six patients (15%) needed a postoperative tracheotomy in the control group because of a prolonged MV >7 days. Tracheotomy was associated with a reduced need of NIV (P=0.04). There was no difference in 60-day mortality rate, cardiac complications, intensive care unit and hospital length of stay. No death was related with the tracheotomy. CONCLUSIONS: Prophylactic tracheotomy in patients with ppo FEV1 <50% who underwent thoracotomy for lung cancer resection provided benefits in terms of duration of prolonged MV and respiratory complications but was not associated with a decreased mortality rate, ICU and hospital length of stay and non-respiratory complications.


Subject(s)
Lung Neoplasms/surgery , Lung/surgery , Pneumonectomy , Respiration, Artificial , Respiratory Tract Diseases/therapy , Thoracotomy , Tracheotomy , Aged , Female , Forced Expiratory Volume , France , Humans , Length of Stay , Lung/pathology , Lung/physiopathology , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Lung Neoplasms/physiopathology , Male , Middle Aged , Pneumonectomy/adverse effects , Pneumonectomy/mortality , Prospective Studies , Recovery of Function , Respiration, Artificial/adverse effects , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/mortality , Respiratory Tract Diseases/physiopathology , Risk Factors , Thoracotomy/adverse effects , Thoracotomy/mortality , Time Factors , Tracheotomy/adverse effects , Tracheotomy/mortality , Treatment Outcome
5.
Chin Clin Oncol ; 4(4): 43, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26730755

ABSTRACT

Only few reports of surgical approach to T4 lung carcinoma invading the heart have been reported in the medical literature. It is also controversial if such cancer should be treated by surgery. The aim of this review is to assess the current risk/benefit ratio of the surgical management of non-small cell lung cancer (NSCLC) invading the left atrium, especially in the light of a multidisciplinary approach. We also expose our surgical experience and the procedure we have developed in order to increase our rate of complete resection as this criterion appears to be mandatory as well as patients' nodal status in order to increase life expectancy.


Subject(s)
Carcinoma, Non-Small-Cell Lung/surgery , Cardiac Surgical Procedures , Heart Atria/surgery , Lung Neoplasms/surgery , Pneumonectomy , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/mortality , Heart Atria/pathology , Humans , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Neoplasm Invasiveness , Patient Selection , Pneumonectomy/adverse effects , Pneumonectomy/mortality , Risk Factors , Treatment Outcome
6.
Nutr Cancer ; 66(7): 1092-6, 2014.
Article in English | MEDLINE | ID: mdl-25157743

ABSTRACT

Weight gain has been reported in early stage breast cancer patients during chemotherapy, but the involved mechanisms remain unclear. A chemotherapy-induced decrease of brown adipose tissue (BAT) activity may partly contribute to weight gain in these patients. A positron emission tomography/computed tomography scan was performed at baseline and after 1 course of docetaxel + trastuzumab treatment in 26 breast cancer women. Variation of the maximal standardized uptake value of BAT in the cervical and supraclavicular regions between the 2 measures was assessed according to weight changes. Overall, (18)F-FDG uptakes in BAT decreased by 11.3% after 1 course of chemotherapy (p = 0.03). No correlation was found between the baseline values of (18)F-FDG uptake and body mass index or age of patients, but as expected (18)F-FDG uptake was dependent on season period. Among the patients, 35% gained weight, 25% lost weight, and 40% remained stable. Women who gained weight during chemotherapy experienced a significant decrease of (18)F-FDG uptake in BAT (p = 0.005). Decreased activity of BAT was associated with body weight gain during chemotherapy. These original data suggest for the first time that BAT modulation by chemotherapy would be a potential contributor to body weight gain through blunted thermogenesis in breast cancer patients.


Subject(s)
Adipose Tissue, Brown/drug effects , Breast Neoplasms/drug therapy , Weight Gain/drug effects , Adipose Tissue, Brown/metabolism , Adult , Antibodies, Monoclonal, Humanized/therapeutic use , Body Mass Index , Docetaxel , Female , Fluorodeoxyglucose F18/administration & dosage , Fluorodeoxyglucose F18/pharmacokinetics , Humans , Middle Aged , Pilot Projects , Positron-Emission Tomography , Taxoids/therapeutic use , Tomography, X-Ray Computed , Trastuzumab
7.
Ann Thorac Surg ; 97(5): 1708-13, 2014 May.
Article in English | MEDLINE | ID: mdl-24625436

ABSTRACT

BACKGROUND: Extended resection for lung cancer may improve survival of selected patients. Left-atrial resection is infrequently performed and surgical techniques are rarely reported; thus, oncologic results and survival rates remain uncertain. Our study describes surgical techniques, postoperative outcomes, and oncologic results of patients who received a combined multimodality treatment. METHODS: Between October 2004 and March 2012 in our institution, 19 patients underwent extended lung resection involving the left atrium without cardiopulmonary bypass. We reviewed perioperative treatments, surgical procedures, and postoperative morbidity, mortality, and long-term survival rates. RESULTS: Sixteen patients (68.4%) underwent neoadjuvant treatment including chemotherapy or radiotherapy. Eighteen pneumonectomies (94.7%) were performed, of which 12 (63.1%) were right sided. Dissection of the interatrial septum was complete in 4 patients (33.3%). Complete resection was achieved in 17 patients (89.4%) and 2 other patients (10.5%) were considered R1. The T-status was pT4 in all patients. Overall postoperative morbidity was 52.6%. The 30-day mortality rate was 10.5% and the 90-day mortality rate was 15.7%. Fifteen patients (93.7%) underwent adjuvant treatment. The mean follow-up time was 32.5 months. The 5-year probability of survival was 43.7%. Three patients (15.7%) were alive at greater than 6 years postsurgery. CONCLUSIONS: Extended lung surgery with partial resection of the left atrium is a feasible procedure with acceptable morbidity. An interatrial septum dissection, by increasing the length of the atrial cuff, allows complete resection. Long-term survival can be achieved in highly selected patients who have undergone multimodal therapy.


Subject(s)
Carcinoma, Non-Small-Cell Lung/therapy , Heart Atria/surgery , Lung Neoplasms/therapy , Neoadjuvant Therapy , Pneumonectomy/methods , Adult , Aged , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Cardiac Surgical Procedures/methods , Cardiopulmonary Bypass , Chemoradiotherapy/methods , Cohort Studies , Databases, Factual , Disease-Free Survival , Female , Heart Atria/pathology , Humans , Kaplan-Meier Estimate , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Invasiveness/pathology , Neoplasm Staging , Prognosis , Proportional Hazards Models , Retrospective Studies , Survival Analysis
8.
Bull Cancer ; 100(9): 865-70, 2013 Sep.
Article in French | MEDLINE | ID: mdl-24045219

ABSTRACT

Numerous studies have demonstrated that a significant change in weight during chemotherapy treatment was a factor of poor prognosis in early breast cancer women. However, the causes and mechanisms involved in this phenomenon are not fully known. This review summarizes current knowledge about the causes of energy imbalance during chemotherapy treatment and the mechanisms that have been proposed as responsible for the increased risk of relapse and death in this population. Current preventive strategies focus on physical activity programs but also on the use of metformin during and after chemotherapy.


Subject(s)
Breast Neoplasms/drug therapy , Weight Gain/physiology , Weight Loss/physiology , Adiposity/physiology , Antineoplastic Agents/adverse effects , Breast Neoplasms/mortality , Breast Neoplasms/pathology , Breast Neoplasms/physiopathology , Energy Metabolism/drug effects , Energy Metabolism/physiology , Exercise/physiology , Female , Humans , Hypoglycemic Agents/therapeutic use , Metformin/therapeutic use , Neoplasm Recurrence, Local/mortality , Physical Conditioning, Human
9.
Surg Radiol Anat ; 30(4): 369-73, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18330490

ABSTRACT

BACKGROUND: The interatrial septum (IAS) can be dissected to resect pulmonary tumors invading the left atrium. The aim of this study was to describe the dissected structures, and to expose the benefits, the limits, and the embryologic reasons of such dissection. METHODS: We dissected the IAS of 11 fresh, non-embalmed human hearts. The dissected structures were described and the length and depth of the dissection were measured. A histological study was performed in four other fresh hearts to identify and differentiate between dissectible and non-dissectible structures. RESULTS: The dissection was performed through a fatty tissue located between two muscular walls. The depth limit of the IAS dissection was identified as the limbus of the fossa ovalis and the muscular roof of the atria. The section of the latter doubles the depth of the dissection at the level of the upper pulmonary veins. Mean length of the dissected IAS was 77 mm (55-90). Mean depths of the IAS were 41 mm (35-50) at the level of the left upper pulmonary vein, 27 mm (12-35) between the upper and lower pulmonary veins, and 14 mm (8-20) at the level of the left inferior pulmonary vein CONCLUSION: The surgical dissection of the IAS is performed through the septum secundum that appears as an infold of the atrial wall. The length of the resectable left atrial cuff reaches a mean of 40 mm at the level of the upper pulmonary vein.


Subject(s)
Atrial Septum/anatomy & histology , Dissection/methods , Aged , Aged, 80 and over , Contrast Media , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...